Literature DB >> 15148216

Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression.

A K Eckstein1, B Quadbeck, S Tews, K Mann, C Krüger, C H Mohr, K-P Steuhl, J Esser, R K Gieseler.   

Abstract

AIM: To characterise periorbital immune cells (stages, kinetics) in active and inactive thyroid associated ophthalmopathy (A-TAO; I-TAO).
METHODS: In orbital tissue cryosections of patients with A-TAO (n = 15), I-TAO (n = 11), and healthy controls (n = 14), adipose and fibrovascular areas were evaluated for MHC II(+) cells, CD45(+) total leukocytes, myeloid cells (CD33(+) monocytes; CD14(+) macrophages; mature RFD7(+) macrophages; RFD1(+) dendritic cells (DCs)), and lymphoid cells (CD4(+) T cells; alphabeta and gammadelta T cells; CD20(+) B cells). Results are expressed as medians and 5% confidence intervals.
RESULTS: In fibrovascular septae, a surge of CD33(+) immigrants clearly correlating with disease activity generated significantly increased (p<0.05) percentages of CD14(+) and RFD7(+) macrophages. Intriguingly, CD4(+) cells were mostly gammadelta T cells, while alphabeta T helper cells were much less frequent. Successful treatment rendering TAO inactive apparently downregulates monocyte influx, macrophage differentiation, and T cell receptor expression. Similar trends were recorded for adipose tissue. Interestingly, RFD1(+) DCs were completely absent from all conditions examined.
CONCLUSION: A-TAO coincides with periorbital monocyte infiltration and de novo differentiation of macrophages, but not DCs. The authors discuss a novel potential role for inflammatory CD4(+) gammadelta T cells in TAO. Successful treatment apparently downregulates orbital monocyte recruitment and effects functional T cell knockout.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148216      PMCID: PMC1772193          DOI: 10.1136/bjo.2003.035915

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  48 in total

1.  Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO).

Authors:  A Pappa; V Calder; R Ajjan; P Fells; M Ludgate; A P Weetman; S Lightman
Journal:  Clin Exp Immunol       Date:  1997-08       Impact factor: 4.330

2.  Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts.

Authors:  A E Heufelder; R S Bahn
Journal:  Eur J Clin Invest       Date:  1992-08       Impact factor: 4.686

3.  Dendritic accessory cells derived from rat bone marrow precursors under chemically defined conditions in vitro belong to the myeloid lineage.

Authors:  R K Gieseler; R A Röber; R Kuhn; K Weber; M Osborn; J H Peters
Journal:  Eur J Cell Biol       Date:  1991-02       Impact factor: 4.492

4.  Down-regulation and release of CD14 on human monocytes by IL-4 depends on the presence of serum or GM-CSF.

Authors:  J Ruppert; C Schütt; D Ostermeier; J H Peters
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

Review 5.  Pathogenesis of Graves' ophthalmopathy.

Authors:  R S Bahn; A E Heufelder
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

6.  Serum-free differentiation of rat and human dendritic cells, accompanied by acquisition of the nuclear lamins A/C as differentiation markers.

Authors:  R K Gieseler; H Xu; R Schlemminger; J H Peters
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

7.  Effect of dexamethasone on T-cell receptor/CD3 expression.

Authors:  G Migliorati; A Bartoli; G Nocentini; S Ronchetti; R Moraca; C Riccardi
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

8.  Adhesion molecule expression in vivo on extraocular muscles (EOM) in thyroid-associated ophthalmopathy (TAO).

Authors:  A Pappa; V Calder; P Fells; S Lightman
Journal:  Clin Exp Immunol       Date:  1997-05       Impact factor: 4.330

9.  Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy.

Authors:  A E Heufelder; R S Bahn
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

10.  Expression of CD14 correlates with lung function impairment in pulmonary sarcoidosis.

Authors:  A Pforte; A Schiessler; P Gais; B Beer; M Ehlers; C Schütt; H W Ziegler-Heitbrock
Journal:  Chest       Date:  1994-02       Impact factor: 9.410

View more
  15 in total

Review 1.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 2.  TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.

Authors:  Terry J Smith
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

Review 3.  Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.

Authors:  Y P Hai; A C H Lee; L Frommer; T Diana; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2019-09-19       Impact factor: 4.256

4.  MicroRNA-146a contributes to CD4+ T lymphocyte differentiation in patients with thyroid ophthalmopathy.

Authors:  Wen-Juan Yang; Peng-Fei Ma; Shu-Ping Li; Hong Su; Yun-Jia Liu
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

5.  Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy.

Authors:  Giovanna Rotondo Dottore; Liborio Torregrossa; Patrizio Caturegli; Ilaria Ionni; Angela Sframeli; Elena Sabini; Francesca Menconi; Paolo Piaggi; Stefano Sellari-Franceschini; Marco Nardi; Francesco Latrofa; Paolo Vitti; Claudio Marcocci; Fulvio Basolo; Michele Marinò
Journal:  JAMA Ophthalmol       Date:  2018-06-01       Impact factor: 7.389

6.  Blood-aqueous barrier integrity in patients with Graves' ophthalmopathy (GO), before and after rehabilitative surgery.

Authors:  A Kłysik; M Kozakiewicz
Journal:  Eye (Lond)       Date:  2015-02-13       Impact factor: 3.775

7.  Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17.

Authors:  Neil Hoa; Shanli Tsui; Nikoo F Afifiyan; Amiya Sinha Hikim; Bin Li; Raymond S Douglas; Terry J Smith
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

8.  Benzylideneacetophenone derivatives attenuate IFN-γ-induced IP-10/CXCL10 production in orbital fibroblasts of patients with thyroid-associated ophthalmopathy through STAT-1 inhibition.

Authors:  Sung-Hee Lee; Seul Ye Lim; Ji Ha Choi; Jae-Chul Jung; Seikwan Oh; Koung Hoon Kook; Youn-Hee Choi
Journal:  Exp Mol Med       Date:  2014-06-13       Impact factor: 8.718

9.  Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy.

Authors:  Yunhai Tu; Yilong Wang; Luna Ding; Jiao Zhang; Wencan Wu
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

10.  Markers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implications.

Authors:  Przemyslaw Pawlowski; Joanna Reszec; Anja Eckstein; Kristian Johnson; Andrzej Grzybowski; Lech Chyczewski; Janusz Mysliwiec
Journal:  Mediators Inflamm       Date:  2014-09-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.